Errors in modeling misrepresent the utility of the enhanced liver fibrosis test in the management of non-alcoholic fatty liver disease
- PMID: 32994080
- DOI: 10.1016/j.jhep.2020.07.009
Errors in modeling misrepresent the utility of the enhanced liver fibrosis test in the management of non-alcoholic fatty liver disease
Conflict of interest statement
Conflict of interest WMR is an inventor of the ELF test and is named on an issued patent. He has not received royalties in relation to this patent. He has received grant support for research and speaker's fees from Siemens Healthineers. AS has received speaker's fees from Siemens Healthineers. ST has no conflicts to declare. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment in
-
Reply to: "Errors in modeling misrepresent the utility of the enhanced liver fibrosis test in the management of non-alcoholic fatty liver disease".J Hepatol. 2020 Dec;73(6):1582-1583. doi: 10.1016/j.jhep.2020.08.007. Epub 2020 Sep 17. J Hepatol. 2020. PMID: 32951911 No abstract available.
Comment on
-
Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis.J Hepatol. 2020 Aug;73(2):252-262. doi: 10.1016/j.jhep.2020.03.036. Epub 2020 Apr 8. J Hepatol. 2020. PMID: 32275982
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
